The article critiques a new resolution by the Federal Council of Medicine in Brazil that is seen as regressive in the context of healthcare innovations.
The article discusses significant advancements in healthcare and medical technology, particularly the adoption of telehealth which has become vital since the COVID-19 pandemic. Despite these advancements, a new resolution (2.448/25) from the Federal Council of Medicine (CFM) is criticized for proposing regulations that could hinder patient access to medical procedures and diminish safety. Instead of supporting innovation, the resolution is perceived as a step backward in the ongoing effort to enhance healthcare delivery in Brazil.
The piece highlights the surprise and concern among healthcare advocates, particularly in light of the ongoing technological innovations that have aimed to improve patient accessibility and outcomes. The Federation of Health Supplementation (FenaSaúde), along with major health cooperatives, has voiced opposition to the resolution, emphasizing the rights of over 53 million Brazilians who rely on health plans. This criticism underscores a broader tension in Brazilian healthcare policy where regulatory decisions can significantly impact patient care and access to essential services.
The article serves as both a critique and a call to action, urging stakeholders in the healthcare sector to advocate for policies that prioritize patient welfare and support innovative practices rather than stifling them. It raises important questions about the balance between regulation and innovation in healthcare, indicating a critical moment for the future of Brazilian medical practices and patient rights.
